Amphastar Pharmaceuticals, Inc. (AMPH)
25.87
-0.55
(-2.08%)
USD |
NASDAQ |
Oct 16, 16:00
25.86
-0.01
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Free Cash Flow (Quarterly) : 42.73M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.73M |
| March 31, 2026 | 38.33M |
| December 31, 2025 | 24.59M |
| September 30, 2025 | 47.24M |
| June 30, 2025 | 22.78M |
| March 31, 2025 | 24.38M |
| December 31, 2024 | 16.61M |
| September 30, 2024 | 46.17M |
| June 30, 2024 | 63.06M |
| March 31, 2024 | 46.50M |
| December 31, 2023 | 14.42M |
| September 30, 2023 | 54.14M |
| June 30, 2023 | 45.87M |
| March 31, 2023 | 30.90M |
| December 31, 2022 | 8.913M |
| September 30, 2022 | 14.44M |
| June 30, 2022 | -3.236M |
| March 31, 2022 | 44.63M |
| December 31, 2021 | 33.56M |
| September 30, 2021 | -4.65M |
| June 30, 2021 | 26.42M |
| March 31, 2021 | 15.21M |
| December 31, 2020 | 7.564M |
| September 30, 2020 | 3.176M |
| June 30, 2020 | 19.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.529M |
| December 31, 2019 | -2.758M |
| September 30, 2019 | -20.68M |
| June 30, 2019 | 42.00M |
| March 31, 2019 | -18.50M |
| December 31, 2018 | -0.065M |
| September 30, 2018 | 3.146M |
| June 30, 2018 | -7.718M |
| March 31, 2018 | -3.98M |
| December 31, 2017 | -0.353M |
| September 30, 2017 | -8.941M |
| June 30, 2017 | -1.727M |
| March 31, 2017 | 15.13M |
| December 31, 2016 | 8.669M |
| September 30, 2016 | -5.403M |
| June 30, 2016 | 3.928M |
| March 31, 2016 | 9.984M |
| December 31, 2015 | -1.275M |
| September 30, 2015 | 1.075M |
| June 30, 2015 | -1.459M |
| March 31, 2015 | -3.707M |
| December 31, 2014 | 2.942M |
| September 30, 2014 | 10.34M |
| June 30, 2014 | -2.669M |
| March 31, 2014 | -10.06M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Viatris, Inc. | 328.00M |
| Johnson & Johnson | 7.295B |
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |
| Pfizer Inc. | 302.00M |